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Evaluation of efficacy of school-based
anthelmintic treatments against anaemia
in children in the United Republic of Tanzania
Helen L. Guyatt,1 Simon Brooker,1 Charles M. Kihamia,2 Andrew Hall,1, 3 & Donald A.P. Bundy1, 3
Objective To determine the impact of deworming on anaemia as part of a large-scale school-based anthelmintic
treatment programme in the Tanga Region of the United Republic of Tanzania.
Methods Both the reduction in the prevalence of anaemia and the cost per case prevented were taken into
consideration. Cross-sectional studies involved parasitological examination and anaemia evaluation before and at
10 months and 15 months after schoolchildren were dewormed.
Findings Baseline studies indicated that the prevalence of anaemia (haemoglobin < 110 g/l) was high (54%)
among schoolchildren, particularly those with high intensities of hookworm and schistosomiasis. Attributable
fraction analysis suggested that hookworm and schistosomiasis were responsible for 6% and 15% of anaemia
cases, respectively. Fifteen months after deworming with albendazole and praziquantel the prevalence of anaemia
was reduced by a quarter and that of moderate-to-severe anaemia (haemoglobin <90 g/l) was reduced by nearly a
half. The delivery of these anthelmintics through the school system was achieved at the relatively low cost of US$ 1
per treated child. The cost per anaemia case prevented by deworming schoolchildren was in the range US$ 6–8,
depending on the haemoglobin threshold used.
Conclusions The results suggested that deworming programmes should be included in public health strategies for
the control of anaemia in schoolchildren where there are high prevalences of hookworm and schistosomiasis.
Keywords Anthelmintics/therapeutic use; Albendazole/therapeutic use/administration and dosage; Praziquan-
tel/therapeutic use/administration and dosage; Anemia/parasitology; Hookworm infections/drug therapy/
complications; Schistosomiasis/drug therapy/complications; Child; School health services; Cross-sectional studies;
Logistic models; Regression analysis; United Republic of Tanzania (source: MeSH ).
Mots cle´s Antihelminthiques/usage the´rapeutique; Albendazole/usage the´rapeutique/administration et posolo-
gie; Praziquantel/usage the´rapeutique/administration et posologie; Ane´mie/parasitologie; Ankylostomiase/
chimiothe´rapie/complication; Schistosomiase/chimiothe´rapie/complication; Enfant; Service hygie`ne scolaire; Etude
section efficace; Mode`le logistique; Analyse re´gression; Re´publique-Unie de Tanzanie (source: INSERM ).
Palabras clave Antihelmı´nticos/uso terape´utico; Albendazol/uso terape´utico/administracio´n y dosificacio´n;
Praziquantel/uso terape´utico/administracio´n y dosificacio´n; Anemia/parasitologı´a; Infecciones por uncinaria/
quimioterapia/complicaciones; Esquistosomiasis/quimioterapia/complicaciones; Nin˜o; Servicios de salud escolar;
Estudios transversales; Modelos logı´sticos; Ana´lisis de regresio´n; Repu´blica Unida de Tanzanı´a (fuente: BIREME ).
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Introduction
Iron-deficiency anaemia can affect the mental and
motor development of children (1, 2) with potential
long-term consequences for productivity and wage-
earning potential in adulthood (3). Parasitic worms
contribute to iron-deficiency anaemia among chil-
dren in sub-Saharan Africa, the predominant species
being the hookworms Ancylostoma duodenale and
Necator americanus (which inhabit the gut) and
Schistosoma spp. (which inhabit the blood vessels
surrounding the gut and bladder). The amount of
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blood loss resulting from iron-deficiency anaemia
depends on the intensity of infection (4, 5), the
dietary intake of iron (6, 7), and the presence of other
parasitic diseases that can cause blood loss or
haemolysis, such as malaria and Trichuris trichiura
infection (8–10). School-age children are particularly
vulnerable to iron-deficiency anaemia exacerbated by
parasitic infection because they typically harbour the
heaviest worm loads in communities (11). A recent
analysis of the association between hookworm and
anaemia in school-age children in Zanzibar suggested
that 25% of all anaemia cases, 35% of iron-deficiency
anaemia cases, and 73% of severe anaemia cases
could be attributed to hookworm infection (9).
Hookworm has been shown to contribute more than
schistosomiasis or malaria to iron-deficiency anaemia
in school-age children (5, 12).
Infectionswith intestinal worms and Schistosoma
spp. are widespread and common among school-age
children in United Republic of Tanzania. The
Tanzania Partnership for Child Development (Ush-
irikiano wa Kumwendeleza Mtoto Tanzania) was estab-
lished to undertake operations research on the
delivery of mass treatment with anthelmintics to
children through the school system. WHO recom-
mends the mass treatment of all children with
anthelmintic drugs when the prevalence of infection
with intestinal worms or schistosomiasis is greater
than 50% (13). A school health package, comprising
albendazole treatment against intestinal worms,
praziquantel treatment against Schistosoma haemato-
bium, and health education aimed at preventing
reinfection, was issued for children in primary
schools in three districts of Tanga Region. Treatment
with the anthelmintics, delivered through the educa-
tion system at a cost of about US$ 1 per child (14) to
schools where both were needed, led to significantly
improved growth and haemoglobin concentrations.
We report the associations between hookworm,
S. haematobium, and anaemia in this school population
and attempt to evaluate the impact and cost-
effectiveness of the first round of anthelmintic
treatments against anaemia.
Methods
Study population and survey design
The programme of the Tanzania Partnership for
Child Development is being implemented in all
352 government primary schools in Tanga, Muheza,
and Korogwe Districts of Tanga Region on the
country’s north-east coast. The process of interpret-
ing and evaluating the programme is described below
(see also Fig. 1).
1. A survey of intestinal parasitic infection and blood
in urine was undertaken in a small sample of
schools throughout the region in May 1995 using
the Kato–Katz method of stool examination (15).
The prevalence of infection with intestinal worms
was high enough to warrant mass treatment with
albendazole in all schools, and there were foci of
urinary schistosomiasis.
2. A questionnaire survey of self-reported urinary
schistosomiasis, called kichocho in Kiswahili, was
undertaken in August 1995 in all districts of Tanga
Region to identify schools in which the prevalence
of infection was estimated to be greater than 50%
and thus warranted mass treatment (16). Schistosoma
haematobiumwas the predominant species of schisto-
some in Tanga Region. S. mansoni has only been
found in small foci and at a low prevalence (17).
3. A baseline survey was undertaken in March and
April 1996 in 20 randomly selected schools.
Schools were eligible for selection if the pre-
valence of self-reported infection with S. haemato-
bium was estimated to be more than 50%, if there
were more than 150 enrolled pupils, and if there
were likely to be enough children to be studied in
two age groups. Samples of equal numbers ofmale
and female children in the age groups 8–9 years
and 12–14 years were randomly selected for study
in each school. A fresh urine specimen was
collected from each child between 10:00 and
14:00. S. haematobium eggs were collected by
filtering 10 ml of each urine sample through a
polycarbonatemembrane, and their concentration
was expressed as eggs per 10 ml urine. A fresh
faecal sample was examined by the Kato–Katz
technique and the concentration of eggs per g
faeces for each nematode species was determined.
Since the eggs of the two hookworm species
cannot be distinguished apart, the term hook-
worm is used for both. A venous blood sample
was collected in a 50% subsample of children and
the haemoglobin concentration was estimated
using a portable haemoglobinometer (HemoCue,
Sheffield, England). Height was measured with a
stadiometer to an accuracy of 0.1 cm and weight
wasmeasured to an accuracy of 0.1 kg bymeans of
electronic scales. A total of 466 children were
examined for both parasites and their haemoglo-
bin level.
4. In April 1996 all children in all schools in the three
intervention districts received a single dose of
400 mg albendazole against intestinal helminths.
Furthermore, all the children in the schools where
the questionnaire survey had indicated the pre-
valence of S. haematobium to be above 50% received
a single dose of praziquantel at a target dose of
40 mg/kg, determined on the basis of height. With
a view to helping teachers to inform children about
parasitic worms and nutrition, all schools were
provided with flip-charts designed by the Tanzania
Partnership for Child Development.
5. About six weeks after treatment, stool and urine
specimens were collected from 413 children in
10 schools originally surveyed to check that the
prevalence of infection with intestinal worms and
S. haematobium was significantly lower than during
the baseline survey. The children surveyed were
not necessarily the same as those in the baseline
survey.
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6. Ten months after treatment, stool and urine
specimens and blood samples were obtained in
10 schools from 429 children who were originally
included in the baseline survey.
7. In July 1997, some 15 months after the treatments
had been given, a follow-up survey was undertaken
in 20 randomly selected schools and in randomly
selected children. Care was taken to verify that all
children examined in the intervention schools had
been treated with both albendazole and praziquan-
tel. For each child, a urine specimen was examined
quantitatively for S. haematobium eggs, a stool
sample was examined by the Kato–Katz method,
and a fingerprick blood samplewas obtained for the
determination of the haemoglobin concentration.
A total of 1121 children were examined for both
parasites and haemoglobin level.Whereas the use of
capillary blood can lead to the misclassification of
anaemia status in individuals, only very small biases
result in respect of the prevalence of anaemia in a
population or sample of individuals (18).
Data analysis
Anaemia is defined as a haemoglobin level in blood of
<110 g/l; the thresholds for moderate-to-severe
anaemia and severe anaemia are 90 g/l and 70 g/l,
respectively (19). In the present study the recently
published age-specific definitions of anaemia (20)
were also applied: a haemoglobin concentration of
<15 g/l for children aged 5–11 years and of < 120 g/l
for children aged 12–14 years. Height-for-age z-
scores were calculated using the NCHS reference
values. Childrenwith z-scores >2 standard deviations
below the NCHS median height-for-age were
classified as stunted. Differences in the prevalence
of infection or anaemia between groups subdivided
by age or sex were assessed using w2 tests.
Logistic regression models were developed to
assess the effect on being anaemic or not of the
following explanatory variables: age; sex; being
stunted or not; the presence or absence of infection
with hookworm, Ascaris lumbricoides, T. trichiura or
S. haematobium; and different classes of intensity of
infection with hookworm and S. haematobium. The
presence of interactions between the main effects
and confounding effects was determined, and
variables were removed in a stepwise manner.
Adjusted odds ratios were calculated (21). The
statistical analyses were performed using SPSS
(Release 7.0, SPSS, Chicago, IL, 1989–1995).
Attributable fraction analysis provides an
estimate of the proportion of cases of anaemia that
can be attributed to a given parasitic infection for
subjects who are infected (the infected attributable
fraction) and for all subjects whether infected or not
(the population attributable fraction), both of which
were calculated using previously described methods
(22). The analysis was performed by comparing
uninfected and infected individuals, for hookworm
and S. haematobium separately, and for uninfected or
lightly infected children against heavily infected
individuals, using different thresholds: > 750 eggs/g
faeces, > 1250 eggs/g, and > 2500 eggs/g for
hookworm; and > 250 eggs/10ml of urine and more
than 500 eggs/10 ml for S. haematobium. Variance and
95% confidence intervals (CI) for the infected
attributable fraction and the population attributable
fraction were calculated using a previously described
method (23).
Since the logistic regression showed that age
was an important predictor of anaemia, estimates
weighted by age group were also calculated. A
weighted sum technique (24) was used to obtain
estimates of the prevalence ratio, the infected
attributable fraction, and the population attributable
fraction. This approach provided age-specific esti-
mates weighted in proportion to the number of
anaemia cases in each stratum, in accordance with the
formula:
S
j
N cj AFI j
,AFI w = S
j
N cj
where AFI is the infected attributable fraction and
Ncj is the frequency of anaemia cases in each stratum.
The weighted population attributable fraction
was provided by:
S
j
N cj AFP j
.AFP w = S
j
N cj
A previously described method was used to
calculate the 95% CI (25).
Cost-effectiveness analysis
The cost per child treated was US$ 0.23 for
albendazole and US$ 0.79 for praziquantel, i.e.
US$ 1.02 per child treated with both drugs (14).
This represents the price of the drug and all delivery
costs including those of distribution, training, and
prior screening for S. haemaobium. A detailed break-
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down of the cost calculations has been given
previously (14). The total cost per child of
US$ 1.02 comprisesUS$ 0.58 for praziquantel (Cost,
Insurance and Freight, CIF), US$ 0.20 for albenda-
zole (CIF), US$ 0.10 for training, US$ 0.06 for drug
distribution, US$ 0.05 for the schistosomiasis ques-
tionnaire and US$ 0.03 for drug clearance, move-
ment, and repackaging. Albendazole was given to
children in all 352 schools in the three districts,
whereas praziquantel was only given to children in
153 schools where the prevalence of infection was
estimated to be greater than 50%. A total of
39 372 children were treated with both praziquantel
and albendazole at a cost of US $ 40 159.44.
The effectiveness of treatment with both drugs
was assessed as the number of anaemia cases
prevented over 15 months, the approximate period
between treatment and the second post-treatment
survey. This was calculated as the difference between
the proportions of children with anaemia at the
baseline survey and the second survey multiplied by
the number of children treated. The cost per anaemia
case prevented was calculated for a range of thresh-
olds (haemoglobin <70 g/l to <120 g/l).
Comparison districts
In the cost-effectiveness analysis it was assumed that
the reduction in anaemia was caused solely by the
intervention. This was supported by data from the
three neighbouring districts of Handeni, Pangani and
Lushoto, where anthelmintics were not given. In this
comparison area the arithmetic mean haemoglobin
level and the prevalence of anaemia (haemoglobin
<110 g/l) remained unchanged over the evaluation
period: 107.8 g/l and 55%anaemic at baseline (n=443)
compared with 108.5 g/l and 51% anaemic (n = 1024)
at follow-up 15 months later. Since the evaluations in
the comparison and intervention districts were made
within a few weeks of each other, external factors such
as seasonal changes in food availability were unlikely to
have had a confounding effect. The data from these
areas were also comparable in terms of malaria
transmission: the inclusion criterion of schistosomiasis
prevalence exceeding 50% meant that all highland
schools were excluded.
Results
Baseline parasitology and anaemia
The baseline survey of 466 children in Muheza,
Tanga, and Korogwe districts suggested that 87% of
children aged 8–14 years were infected with at least
one of the helminth species examined (intestinal
nematodes and S. haematobium). The most common
parasites were hookworms (61%) and S. haematobium
(59%) and many children (37%) were infected with
both of these; in only 17% of children were both of
these parasites absent. In approximately 20% of the
children there weremore than 750 hookworm eggs/g
faeces and more than 250 S. haematobium eggs/10ml
of urine.A. lumbricoides and T. trichiurawere present at
low levels in 21% and 14% of children, respectively.
Both the prevalence of S. haematobium infection
and heavy infection (egg counts >250/10 ml) were
significantly higher in children aged 11–14 years than
in those aged 8–10 years (63% vs. 50% (P < 0.005)
and 21 % vs. 9% (P < 0.01), respectively). In
contrast, the prevalence of hookworm infection or
heavy infection did not differ significantly between
the age groups.
A total of 54% of the children had haemoglo-
bin values < 110 g/l, and 10% had moderate-to-
severe anaemia (< 90 g/l). Severe anaemia (<70 g/l)
was identified in fewer than 2% of the children. Over
two-thirds of the children were stunted and the
prevalence of anaemia was slightly higher in this
group (56% vs. 50%, P = 0.20). Anaemia was
strongly associated with the intensity of infection
with hookworm and S. haematobium (Table 1). Logistic
regression analysis revealed that age group, stunting
and the intensity of infection with hookworm and
S. haematobium were the important predictive vari-
ables for anaemia ( haemoglobin < 110 g/l) (Table 2).
Infection with A. lumbricoides or T. trichiura was not
related to anaemia.
Table 3 summarizes the attributable fraction
analysis for the association between helminth infec-
tion and anaemia. The unweighted analysis suggests
that 6% of anaemia cases (<110 g/l haemoglobin)
could be attributed to hookworm. The attributable
fraction was 0.16 for children aged 8–10 years and
0.05 for those aged 11–14 years. The unweighted
population-attributable fraction for S. haematobium
was more than twice that for hookworm at 15%. The
estimated risk of anaemia associated with S. haema-
tobium was 0.9 among children aged 8–10 years and
0.12 among those aged 11–14 years. The differences
in the attributable fractions of the two infections by
age was caused by the differences in the prevalence of
infection and anaemia between the age groups. In the
case of S. haematobium, the prevalence was higher
among older children, whereas for hookworm
infection there was no difference between the age
groups. The prevalence of anaemia, in contrast, was
higher among younger children. As a result, the
weighted attributable fraction estimates (both at
10%) were higher than the crude estimates for
hookworm infection and lower for S. haematobium
(Table 3). The proportions of moderate-to-severe
anaemia cases (haemoglobin < 90 g/l) attributable to
hookworm and schistosomiasis were higher at 14%
and 25%, respectively.
Impact of treatment
Fig. 2 illustrates the changes in hookworm and
S. haematobium infection at intervals of 6 weeks,
10 months, and 15 months after the baseline survey
— treatment having been administered just after this
survey. At 6 weeks the prevalences of hookworm and
S. haematobium had been reduced by 82% and 94%,
respectively (Fig. 2). The prevalence of heavy
698 Bulletin of the World Health Organization, 2001, 79 (8)
Research
infection was reduced by more than 97%, and the
mean intensities of infection of hookworm and S.
haematobium fell from 738 eggs/g to 18 eggs/g and
from 194 eggs/10 ml to 2 eggs/10 ml, respectively.
The surveys at 10 months and 15 months after
treatment suggested a steady increase in the
prevalence of infection, particularly that of hook-
worm. At 15 months the prevalence of hookworm
(49%) had increased to almost the pretreatment
value, whereas that of S. haematobium (24%) was less
than half the pretreatment value. The prevalence of
heavy infection for both species remained below 50%
of the pretreatment level (Fig. 2).
The changes in anaemia after treatment are
summarized in Table 4. An improvement in anaemic
status, as defined by mean haemoglobin and a
haemoglobin level <110 g/l, only became evident
15 months after treatment, when the administration of
albendazole and praziquantel appeared to have
reduced the prevalence of anaemia by a quarter and
the prevalence of moderate-to-severe anaemia by
almost 50%. The difference in the prevalence of
anaemia between the baseline survey and follow-up
15 months later was used to estimate the proportion of
anaemia cases prevented. Among the 39 372 children
treated with both albendazole and praziquantel,
281 cases of severe anaemia (haemoglobin < 70 g/l)
were prevented; for moderate-to-severe anaemia
(< 90 g/l) and anaemia (<110 g/l) the numbers of
cases prevented were 1445 and 5661, respectively. The
cost for preventing these cases was US$ 40 150.44, the
total cost of mass treatment with albendazole and
praziquantel. The costs per anaemia case prevented are
illustrated in Fig. 3 for a range of haemoglobin cut-offs
(70–120 g/l at intervals of 5 g/l). The relationship was
markedly non-linear: the cost per anaemia case
prevented was high and variable at low haemoglobin
thresholds but relatively stable (<US$ 10) at thresh-
olds above 100 g/l. Using a haemoglobin threshold of
<110 g/l for anaemia corresponds to a cost per case
prevented of US$ 7.23, increasing to US$ 145.71 for a
case of severe anaemia prevented (< 70g/l).
Discussion
The present study indicates that infection with
hookworm and schistosomiasis could be responsible
for 6% and 15%, respectively, of anaemia cases in
school-age children (10% for both if weighted by age)
in an area where the prevalence of both infections
was estimated to be greater than 50%. If anthelmintic
drugs were to reduce infection by 100%, concurrent
relative reductions in the prevalence of anaemia
would be predicted. In fact, treatment with albenda-
zole and praziquantel reduced the prevalence of
anaemia by 26% up to 15 months after deworming.
This was achieved without iron supplementation.
Combining these data with those on the costs of
delivery and treatment suggests that the cost per
anaemia case prevented over 15 months could be
US$ 7.43 if the school system is used to deliver
anthlemintics. Furthermore, these effects are likely to
last longer than 15 months, since the intensities of
hookworm and schistosomiasis infection, important
factors in the causation of anaemia, had still not
recovered to pretreatment values.
In order to place these results in context it is
necessary to make similar calculations on the cost per
anaemia case prevented for other interventions that
improve anaemia status. The cost per moderate-to-
severe anaemia case (haemoglobin < 90 g/l) pre-
vented during one year of mebendazole treatment
(three times a year) of 30 000 schoolchildren on
Zanzibar was US$ 3.57; for severe anaemia (haemo-
globin <70 g/l) the corresponding cost was
US$ 16.30 (19). This is approximately an eighth of
the cost estimated in the present analysis for a single
treatment with praziquantel and albendazole. The
difference arises because of the very low cost of
Table 1. Association between anaemia and intensity of helminth
infection, Tanga Region, United Republic of Tanzania, March–
April 1996
Helminth n % Prevalence % Prevalence Mean
infection of anaemia of moderate-to haemoglobin
(<110g/l) -severe anaemia level
(<110g/l) (mg/l)
Hookworm (eggs/g)
Uninfected 172 50.6 6.4 108.8 (13.4)a
>0 eggs/g 294 56.1 11.6 106.5 (15.1)
>750 eggs/g 108 63.0 13.9 103.9 (14.9)
>1250 eggs/g 62 59.7 16.1 103.0 (16.0)
>2500 eggs/g 33 75.8 27.3 97.9 (17.0)
S. haematobium
(eggs/10 ml)
Uninfected 199 46.2 7.5 110.0 (14.5)
>0 eggs/10ml 267 59.9 11.2 105.3 (14.3)
>250 eggs/10ml 82 73.2 15.9 101.5 (14.3)
>500 eggs/10ml 52 75.0 15.4 100.8 (14.3)
a Figures in parentheses are 95% confidence intervals.
Table 2. Logistic regression analysis of factors affecting the risk of
being anaemic (haemoglobin <110 g/l), with calculated odds ratios
Main effects Coefficient Standard P–value Odds ratio
(B) Error of B
Constant –2.52 0.16
Age group
(1 = 8–10 years, –0.54 0.15 <0.001 0.59 (0.44–0.79)
2 = 11–14 years)
S. haematobium a 0.33 0.08 <0.001 1.39 (1.19–1.62)
Hookwormb 0.16 0.06 <0.006 1.17 (1.05–1.32)
Stunted (1 = yes, 2 = no) 0.45 0.16 <0.005 1.57 (1.14–2.15)
a 0 = uninfected, 1 = 1–249 eggs/10 ml, 2 = 250–499 eggs/10 ml, 3 = =500 eggs/10 ml.
b 0 = uninfected, 1 = 1–749 eggs/g, 2 = 750–1249 eggs/g, 3 = 1250–2499 eggs/g,
4 = =2500 eggs/g.
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mebendazole, estimated to be US$ 0.08 per child per
year plus US$ 0.07 for delivery. The combined
treatment with albendazole and praziquantel is more
expensive but is of comparable effectiveness.
Assuming an equivalent population of 30 000, a
single treatment with albendazole and praziquantel
would reduce by 1080 the number of moderate-to-
severe anaemia cases in the present study in the
United Republic of Tanzania over 15 months,
compared with 1208 cases prevented in Zanzibar as
a result of using mebendazole three times in
12 months. These analyses are not directly compar-
able since there are variations in the time frame for
effectiveness (longer in the present study), the levels
of infection and anaemia at baseline, and the
methodologies employed to estimate cases pre-
vented (in the Zanzibar study, extrapolation was
performed from incidences in control and treatment
groups over 6 months). However, the analysis
provides some indication of the potential effective-
ness of employing anthelmintics in reducing anaemia
in schoolchildren.
Improvements in haemoglobin levels were not
detected until at least 10 months after anthelmintic
treatment. It had previously been concluded that,
whereas iron supplementation can lead to rapid
improvements in haemoglobin levels, the effects of
deworming may appear up to 15–20 months after
treatment (6). A more detailed follow-up survey
including other indicators of anaemia, such as ferritin,
may shed more light on this apparent delay in
haemoglobin recovery.
The most traditional approach to improving
iron balance is to use iron supplementation. How-
ever, we found no studies in the literature that
presented the cost per anaemia case prevented. A
recent economic analysis assessed the cost-effective-
ness, expressed as cost per averted disability-adjusted
life year, of oral iron supplementation in preventing
severe anaemia (packed cell volume <25%) among
infants in the United Republic of Tanzania (26). This
outcomemeasure permits comparison across disease
conditions, but requires many assumptions in
translating cases into years of disability and death.
Unfortunately, the costs in terms of cases prevented
were not indicated, but it is possible to get some
indication of them by referring back to the control
trial on which the analysis was based (27). If, for
example, 40% of infants have severe anaemia, and
iron supplementation prevents 30% of severe cases
in the first year of life, the cost per severe case
prevented would be US$ 14.77 at 1996 prices,
assuming an intervention cost of US$ 4121 for
2322 infants (26). In an operational setting, however,
effectivenessmay bemarkedly diminished because of
the failure of patients to adhere to a therapy that
involves multiple treatments. Furthermore, although
the cost of iron supplements may be low, i.e.
< US$ 0.10 per year for a school-age child, the cost
of delivery may be high unless existing channels such
as those of the health and school systems are utilized.
The cost–benefits of iron supplementation in adults
were assessed in terms of increased productivity for
improvement in negative iron balances (28). For
Indonesia the resulting cost–benefit ratio was around
Table 3. Attributable fraction analysis for anaemia and helminth
infection
Anaemia Prevalence Crude Age-weighted
level/Intensity of infectiona ratio (PRw) population population
attributable attributable
fraction fraction
Hb < 110 g/l
Hookworm (eggs/g)
>0 1.19 0.06 0.10
(0–0.27)
>750 1.29 0.05 0.06
(0–0.13)
>1250 1.28 0.02 0.04
(0–0.09)
>2500 1.44 0.03 0.03
(0–0.07)
Schistosoma haematobium
(eggs/10ml)
>0 1.19 0.15 0.10
(0-0.26)
>250 1.13 0.08 0.03
(0–0.10)
>500 1.14 0.05 0.02
(0–0.08)
Hb <90 g/l
Hookworm (>0) 1.30 0.14 0.14
(0.06–0.23)
S. haematobium (>0) 1.82 0.25 0.25
(0.19–0.30)
Hb <70 g/l
Hookworm (>0) 1.48 0.34 0.22
(0–0.79)
S. haematobium (>0) 0.53 0.15 –b
a Hb = haemoglobin.
b Negative value.
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6; in Mexico it was almost 10 because of substantially
higher wage rates. This suggests that iron supple-
mentation would represent an efficient use of
resources. Although increasing the iron status of
schoolchildren would not directly translate into
increased worker productivity, the improvement of
the anaemia status of this age group is likely to have a
positive effect on schooling. For example, cognitive
skills might be increased (1), which would lead to
better employment prospects and wage-earning
capacity in adulthood (3). Stunting affects school
performance adversely (29–31); adults of relatively
short stature are less productive than taller adults (32,
33). Growth places demands on iron levels, and thus
these two health outcomes are intrinsically related.
With regard to the deworming of schoolchildren, the
subsequent improvements in relation to both
anaemia and stunting are particularly important (19,
34, 35). In addition there are direct associations
between intestinal nematode infection and cognitive
achievement. Expressing effectiveness as anaemia
cases prevented clearly underestimates the full
potential benefits of deworming on the mental and
physical development of schoolchildren.
For ethical reasons, different children were
sampled in each survey of the present study.
Consequently, the reported changes in anaemia are
only trends. A cohort design would have been more
precise. Furthermore, the costs did not include that
of health education materials. Two flip-charts were
provided for each school at a cost of US$ 17 per
chart, increasing the cost per anaemia case prevented
to US$ 8.01. As anecdotal evidence suggests that the
teachers did not use the charts, however, it is unlikely
that they helped to reduce the prevalence of anaemia.
We have shown that school-based deworming
programmes can favourably influence the anaemia
status of children at a cost of US$ 6–8 per anaemia
case prevented over 15 months. The regular
deworming of schoolchildren should therefore be
given serious consideration as an approach to
anaemia control and should be assessed in relation
to iron supplementation and other traditional ways of
improving iron status. n
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Re´sume´
Re´publique-Unie de Tanzanie : e´valuation de l’efficacite´ des traitements anthelminthi-
ques en milieu scolaire pour lutter contre l’ane´mie chez l’enfant
Objectif De´terminer l’effet du traitement vermifuge sur
l’ane´mie dans le cadre d’un programme a` grande e´chelle
de traitement par les anthelminthiques dans les e´coles de
la re´gion de Tanga, en Re´publique-Unie de Tanzanie.
Me´thodes On a tenu compte a` la fois de la re´duction de
la pre´valence de l’ane´mie et du couˆt par cas e´vite´. Dans
les e´tudes transversales, on a effectue´ un examen
parasitologique et une e´valuation de l’ane´mie chez les
e´coliers avant le traitement vermifuge, puis 10 et 15 mois
apre`s.
Re´sultats Au de´part, les e´tudes indiquaient que la
pre´valence de l’ane´mie (he´moglobine <110 g/l) e´tait
Table 4. Effect of mass treatment with albendazole and praziquantel
on anaemia in school-age children
Anaemia Baseline 10 months 15 months
pretreatment post– post–
(n = 466) treatment treatment
(n = 429) (n = 1121)
Mean haemoglobin level (g/l) 107.3 (14.5)a 108.0 (13.2) 112.8 (15.1)
Prevalence of anaemia
Hb <110 g/l 54.1% 52.7% 40.0%
Hb <90 g//l 9.7% 5.8% 6.1%
Hb <70 g/l 1.5% 0.7% 0.8%
a Figures in parentheses are standard deviations.
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e´leve´e (54 %) chez les e´coliers, en particulier chez ceux
qui pre´sentaient de fortes charges parasitaires (anky-
lostomes et schistosomes). L’analyse du risque attri-
buable laisse a` penser que l’ankylostomiase et la
schistosomiase sont responsables de 6 et 15 % des cas
d’ane´mie, respectivement. Quinze mois apre`s le traite-
ment vermifuge par l’albendazole et le praziquantel, la
pre´valence de l’ane´mie avait e´te´ re´duite d’un quart et
celle de l’ane´mie mode´re´e a` grave (he´moglobine <90 g/l)
de pre`s de la moitie´. L’administration de ces anthelmin-
thiques par le biais du syste`me scolaire a e´te´ re´alise´e pour
un couˆt relativement faible de US $1 par enfant traite´. Le
couˆt par cas d’ane´mie e´vite´ en appliquant un traitement
vermifuge aux enfants est de l’ordre de US $6 a` 8, selon
le seuil employe´ pour le taux d’he´moglobine.
Conclusion Ces re´sultats laissent a` penser que des
programmes de traitement vermifuge doivent figurer
dans les strate´gies de sante´ publique pour lutter contre
l’ane´mie chez l’enfant d’aˆge scolaire, lorsque la
pre´valence de l’ankylostomiase et de la schistosomiase
sont e´leve´es.
Resumen
Evaluacio´n de la eficacia de los tratamientos antihelmı´nticos escolares contra la anemia
en nin˜os de la Repu´blica Unida de Tanzanı´a
Objetivo Determinar el impacto del tratamiento vermı´-
fugo en la anemia como parte de un programa de
tratamiento antihelmı´ntico escolar en gran escala
emprendido en la Regio´n de Tanga, Repu´blica Unida
de Tanzanı´a.
Me´todos Se consideraron tanto la reduccio´n de la
prevalencia de la anemia como el costo por caso evitado.
Los estudios transversales realizados comprendı´an el
ana´lisis parasitolo´gico y la evaluacio´n de la anemia antes
del tratamiento vermı´fugo de los escolares y a los 10 y
15 meses del tratamiento.
Resultados Los estudios basales mostraron que la
prevalencia de anemia (hemoglobina < 110 g/l) era
elevada (54%) entre los escolares, en particular en
aquellos que presentaban una alta carga de anquilosto-
ma y esquistosoma. El ana´lisis de la fraccio´n atribuible
permitio´ relacionar la anquilostomiasis y la esquistoso-
miasis con el 6% y el 15% de los casos de anemia,
respectivamente. Quince meses despue´s del tratamiento
vermı´fugo con albendazol y prazicuantel, la prevalencia
de anemia se habı´a reducido en una cuarta parte, y la de
anemia moderada-grave (hemoglobina < 90 g/l) lo
habı´a hecho casi en un 50%. El suministro de esos
antihelmı´nticos a trave´s de las escuelas pudo hacerse a
un costo relativamente bajo, US$ 1 por nin˜o tratado. El
costo por caso de anemia evitado mediante el
tratamiento vermı´fugo de los escolares se situaba en el
intervalo US$ 6–8, dependiendo del umbral de hemo-
globina empleado.
Conclusio´n Los resultados indican que las estrategias
de salud pu´blica deben incluir programas de tratamiento
vermı´fugo para combatir la anemia entre los escolares en
los casos en que concurre una alta prevalencia de
anquilostomiasis y esquistosomiasis.
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